125 related articles for article (PubMed ID: 9565102)
1. Microbiological evaluation of glycerolized cadaveric donor skin.
van Baare J; Ligtvoet EE; Middelkoop E
Transplantation; 1998 Apr; 65(7):966-70. PubMed ID: 9565102
[TBL] [Abstract][Full Text] [Related]
2. The 1998 Lindberg Award. Comparison of glycerol preservation with cryopreservation methods on HIV-1 inactivation.
van Baare J; Cameron PU; Vardaxis N; Pagnon J; Reece J; Middelkoop E; Crowe SM
J Burn Care Rehabil; 1998; 19(6):494-500. PubMed ID: 9848039
[TBL] [Abstract][Full Text] [Related]
3. Maintaining a glycerolized skin bank--a practical approach.
Vuola J; Pipping D
Burns; 2002 Oct; 28 Suppl 1():S31-3. PubMed ID: 12237062
[TBL] [Abstract][Full Text] [Related]
4. Procurement and transplantation of colonized cadaver skin.
White MJ; Whalen JD; Gould JA; Brown GL; Polk HC
Am Surg; 1991 Jun; 57(6):402-7. PubMed ID: 2048856
[TBL] [Abstract][Full Text] [Related]
5. Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi.
Verbeken G; Verween G; De Vos D; Pascual B; De Corte P; Richters C; De Coninck A; Roseeuw D; Ectors N; Rose T; Jennes S; Pirnay JP
Cell Tissue Bank; 2012 Mar; 13(1):1-7. PubMed ID: 21360142
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term bacterial inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts.
Saegeman VS; Ectors NL; Lismont D; Verduyckt B; Verhaegen J
Burns; 2008 Mar; 34(2):205-11. PubMed ID: 18037568
[TBL] [Abstract][Full Text] [Related]
7. Processing efficacy in relation to microbial contamination of skin allografts from 723 donors.
Pianigiani E; Ierardi F; Cuciti C; Brignali S; Oggioni M; Fimiani M
Burns; 2010 May; 36(3):347-51. PubMed ID: 19616385
[TBL] [Abstract][Full Text] [Related]
8. Serologic Evaluation of Cornea Donors and Microbiologic Evaluation of Cornea Storage Media in an Eye Bank from Izmir, Turkey.
Palamar M; Degirmenci C; Sertoz R; Aydemir S; Egrilmez S; Yagci A
Exp Clin Transplant; 2017 Dec; 15(6):685-688. PubMed ID: 27447356
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy.
Pianigiani E; Risulo M; Ierardi F; Sbano P; Andreassi L; Fimiani M; Caudai C; Valensin PE; Zazzi M
Burns; 2006 May; 32(3):348-51. PubMed ID: 16529868
[TBL] [Abstract][Full Text] [Related]
10. Cadaveric allograft discards as a result of positive skin cultures.
Obeng MK; McCauley RL; Barnett JR; Heggers JP; Sheridan K; Schutzler SS
Burns; 2001 May; 27(3):267-71. PubMed ID: 11311520
[TBL] [Abstract][Full Text] [Related]
11. Microbiologic analysis of preservation solutions in cadaveric kidney transplantation.
Haberal M; Demirağ A; Cohen B; Turan M; Arslan G; Bilgin N
Transplant Proc; 1995 Oct; 27(5):2697-8. PubMed ID: 7482879
[No Abstract] [Full Text] [Related]
12. Biomechanical and histological evaluation of glycerol-preserved human sclerae.
Schirmbeck T; Cruz AA
Arq Bras Oftalmol; 2007; 70(6):988-90. PubMed ID: 18235912
[TBL] [Abstract][Full Text] [Related]
13. A simplified testing system to evaluate performance after transplantation of human skin preserved in glycerol or in liquid nitrogen.
Cinamon U; Eldad A; Chaouat M; Wexler MR; Israeli A; Zagher U; Ben-Bassat H
J Burn Care Rehabil; 1993; 14(4):435-9. PubMed ID: 8408168
[TBL] [Abstract][Full Text] [Related]
14. Application of a high-level peracetic acid disinfection protocol to re-process antibiotic disinfected skin allografts.
Lomas RJ; Huang Q; Pegg DE; Kearney JN
Cell Tissue Bank; 2004; 5(1):23-36. PubMed ID: 15256837
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the contamination rate of human organ-cultured corneas.
Röck D; Wude J; Bartz-Schmidt KU; Yoeruek E; Thaler S; Röck T
Acta Ophthalmol; 2017 Dec; 95(8):e706-e712. PubMed ID: 28321999
[TBL] [Abstract][Full Text] [Related]
16. Bacterial contamination of tissue allografts - experiences of the donor tissue bank of Victoria.
Ireland L; Spelman D
Cell Tissue Bank; 2005; 6(3):181-9. PubMed ID: 16151958
[TBL] [Abstract][Full Text] [Related]
17. Organ preservation solutions: linking pharmacology to survival for the donor organ pathway.
Fuller B; Froghi F; Davidson B
Curr Opin Organ Transplant; 2018 Jun; 23(3):361-368. PubMed ID: 29697461
[TBL] [Abstract][Full Text] [Related]
18. Variables determining the amount of microbial contamination on cadaveric allograft skin used as a biological wound dressing.
May SR; Wainwright JF; DeClement FA
Burns Incl Therm Inj; 1985 Apr; 11(4):242-51. PubMed ID: 3891023
[TBL] [Abstract][Full Text] [Related]
19. Glycerol-preserved arterial allografts evaluated in the infrarenal rat aorta.
Fahner PJ; Idu MM; van Gulik TM; van Wijk B; van der Wal AC; Legemate DA
Eur Surg Res; 2009; 42(2):78-86. PubMed ID: 19052464
[TBL] [Abstract][Full Text] [Related]
20. Viability testing in the non-heart-beating donor.
Light J
Transplant Proc; 2000 Feb; 32(1):179-81. PubMed ID: 10701014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
